The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics
Specificity profiling is a requirement for monoclonal antibodies (mAbs) and antibody-directed biotherapeutics such as CAR-T cells prior to initiating human trials. However, traditional approaches to assess the specificity of mAbs, primarily tissue cross-reactivity studies, have been unreliable, lead...
Saved in:
Main Authors: | Diana M. Norden (Author), Carmen T. Navia (Author), Jonathan T. Sullivan (Author), Benjamin J. Doranz (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns
by: Orla Cunningham, et al.
Published: (2021) -
OCT1 Polyspecificity-Friend or Foe?
by: Marleen J. Meyer, et al.
Published: (2021) -
Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position
by: Winter E, et al.
Published: (2014) -
Antibody repertoire profiling with mimotope arrays
by: Shina Pashova, et al.
Published: (2017) -
Predicting Off-Target Binding Profiles With Confidence Using Conformal Prediction
by: Samuel Lampa, et al.
Published: (2018)